MYGN
Myriad Genetics Inc
Price:  
14.43 
USD
Volume:  
1,147,191.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYGN Fair Value

-144.15 %
Upside

As of 2024-12-14, the Fair Value of Myriad Genetics Inc (MYGN) is -6.37 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.43 USD, the upside of Myriad Genetics Inc is -144.15%.

Note: valuation result may not be accurate due to the company's negative EPS.

14.43 USD
Stock Price
-6.37 USD
Fair Price
FAIR VALUE CALCULATION

MYGN Fair Value

Peter Lynch's formula is:

MYGN Fair Value
= Earnings Growth Rate x TTM EPS
MYGN Fair Value
= 5.00 x -1.27
MYGN Fair Value
= -6.37

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-06-30 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -199.50 -53.10 -27.20 -112.00 -263.30 -131.02
YoY growth -4,436.96% 73.38% 48.78% -311.76% -135.09% -952.33%

MYGN Fair Value - Key Data

Market Cap (mil) 1,313.71
P/E
Forward P/E
EPS -1.27
Avg earnings growth rate -952.33%
TTM earnings -116.00